
ACE-031 (ramatercept) is a dimeric fusion of the extracellular domain of the activin receptor type IIB (ActRIIB) and the Fc region of human IgG1. It functions as a decoy receptor, binding myostatin (GDF-8), activin A, and GDF-11 in circulation before they can engage endogenous ActRIIB. Sequestering these negative regulators relieves their suppression of muscle growth; in animal research the result is increased muscle mass and effects on bone density.
Learn more about the science →Identity by SDS-PAGE and anti-Fc Western blot, purity by SEC-HPLC (≥98%), endotoxin by LAL, appearance. As a recombinant fusion protein, ACE-031 is verified on a protein-specific assay panel. Third-party ISO-17025 verified.
View full certificate →Lyophilized: −20°C (−80°C for long-term), 24 months. Reconstitute with sterile water; for storage beyond 24 hours a carrier protein (e.g. 0.1% BSA) is recommended. Reconstituted: 2–8°C short-term; aliquot and avoid repeated freeze-thaw, which degrades fusion proteins.
We ship in insulated parcels with phase-change cooling and a tamper-evident seal.
No — it is a recombinant Fc-fusion protein (the ActRIIB extracellular domain fused to human IgG1 Fc), much larger than the peptides in the rest of the catalog. Handling and storage differ accordingly.
ACE-031 binds myostatin and related TGF-β-family ligands in circulation, preventing them from activating endogenous ActRIIB. Removing that brake is what drives the muscle effects seen in animal models.
Recombinant proteins expressed in mammalian cells carry a different purification profile than synthetic peptides. <1.0 EU/mg is the protein-line operating spec; the actual lot value is on the COA.
Dilute fusion proteins can adsorb to vial surfaces and lose activity. A carrier such as 0.1% BSA is standard for storage beyond 24 hours in research settings.
Research using ACE-031 is typically intermittent rather than continuous, so it ships as a one-time order at launch.
It runs on a protein panel — SDS-PAGE and anti-Fc Western for identity, SEC-HPLC for purity — rather than the LC-MS/HPLC panel used for synthetic peptides.
Provided for context only. None of the studies cited below evaluate hábit material specifically; they document the published literature on the compound and its mechanism. Research-use claims are not therapeutic claims.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Asked support a purity question and got the raw HPLC trace back within the hour. That transparency is why we reorder.”